Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harisa Muratovic

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Neurological Disorders|April 28, 2023
The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional studyAna Klein, Martina Flaskamp, Achim Berthele, et al.
Studies in Health Technology and Informatics|May 23, 2026
Utilizing Routine Care Data of Rare Diseases: Challenges, Chances and Call for CollaborationMiriam Hübner, Marco Schaarschmidt, Harisa Muratovic, et al.
Neurological Research and Practice|September 12, 2025
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteriaDuc Chu Dieu, Helena F Pernice, Harisa Muratovic, et al.
Scientific Reports|May 2, 2024
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosisHelena F Pernice, Adrian L Knorz, Paul J Wetzel, et al.
Scientific Reports|April 24, 2026
Transferability of a US claims-based machine learning model for ATTRwt-CM identification: a retrospective evaluation in a German settingHarisa Muratovic-Colic, Miriam R Hübner, Jan-Filip Rehburg, et al.
Plos One|June 2, 2026
On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry studyHelena Pernice, Gina Barzen, Jakub Piwowarski, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Neurological Disorders|April 28, 2023
The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional studyAna Klein, Martina Flaskamp, Achim Berthele, et al.
Studies in Health Technology and Informatics|May 23, 2026
Utilizing Routine Care Data of Rare Diseases: Challenges, Chances and Call for CollaborationMiriam Hübner, Marco Schaarschmidt, Harisa Muratovic, et al.
Neurological Research and Practice|September 12, 2025
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteriaDuc Chu Dieu, Helena F Pernice, Harisa Muratovic, et al.
Scientific Reports|May 2, 2024
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosisHelena F Pernice, Adrian L Knorz, Paul J Wetzel, et al.
Scientific Reports|April 24, 2026
Transferability of a US claims-based machine learning model for ATTRwt-CM identification: a retrospective evaluation in a German settingHarisa Muratovic-Colic, Miriam R Hübner, Jan-Filip Rehburg, et al.
Plos One|June 2, 2026
On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry studyHelena Pernice, Gina Barzen, Jakub Piwowarski, et al.
Pageof 1